Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27032271 | 0.83 | HSD17B10 (0.44) | TDP1CA1CA2CA7 | |
| SCHEMBL27130526 | 0.83 | HSD17B10 (0.44) | TDP1CA1CA2CA7 | |
| SCHEMBL9388619 | 0.81 | MEN1 (0.39) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL1645830 | 0.79 | — | — | |
| SCHEMBL20820743 | 0.78 | MEN1 (0.41) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL18234052 | 0.77 | ALDH1A1 (0.56) | TDP1 | |
| SCHEMBL9448501 | 0.77 | — | — | |
| SCHEMBL925982 | 0.77 | — | — | |
| SCHEMBL7938725 | 0.77 | MEN1 (0.39) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL827408 | 0.77 | CA1 (0.45) | MEN1POLBKMT2ATDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143362-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | claimed |
| US-20100331444-A1 | COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF | 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) | 2010-12-30 | — | — | US | claimed |
| US-7807730-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M ESPE AG (DE) | 2010-10-05 | — | — | US | claimed |
| EP-1650263-B1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | MINNESOTA MINING MFG GMBH (DE) | 2013-10-23 | — | — | EP | disclosed |
| US-8143362-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-20100331444-A1 | COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF | 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) | 2010-12-30 | — | — | US | disclosed |
| US-7807730-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M ESPE AG (DE) | 2010-10-05 | — | — | US | disclosed |
| CN-100407494-C | Sealing agent for photoelectric conversion element and photoelectric conversion element using the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-07-30 | — | — | CN | disclosed |
| US-20080140037-A1 | Crosslinker for Superabsorbent Polymers | EVONIK STOCKHAUSEN GMBH (DE) | 2008-06-12 | — | — | US | disclosed |
| US-20060111464-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M DEUTSCHLAND GMBH (DE) | 2006-05-25 | — | — | US | disclosed |
| EP-1652889-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M Espe AG (DE) | 2006-05-03 | — | — | EP | disclosed |
| EP-1650263-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M Espe AG (DE) | 2006-04-26 | — | — | EP | disclosed |
| CN-1751410-A | Sealing agent for photoelectric conversion element and photoelectric conversion element using the same | NIPPON KAYAKU KK (JP) | 2006-03-22 | — | — | CN | disclosed |
| US-20060052646-A1 | Process for producing ether compounds in presence of a copper (II) salt | SHOWA DENKO K.K. (JP) | 2006-03-09 | — | — | US | disclosed |
| CN-1674987-A | Process for producing ether compounds in presence of a copper (II) salt | SHOWA DENKO KK (JP) | 2005-09-28 | — | — | CN | disclosed |
| EP-0319829-B1 | Optical material | KUREHA CHEMICAL IND CO LTD (JP) | 1995-07-26 | — | — | EP | disclosed |
| US-4959431-A | Optical material | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-09-25 | — | — | US | disclosed |
| EP-0319829-A2 | Optical material | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052646-A1 | Process for producing ether compounds in presence of a copper (II) salt | ADH1C, AKR7A2, ADH1A | MEN1 2089/4885POLB 1280/4885KMT2A 1029/4885 |
| US-20080140037-A1 | Crosslinker for Superabsorbent Polymers | STOM, PCNA, UROD | MEN1 3649/4885POLB 3001/4885KMT2A 2199/4885 |
| US-20100331444-A1 | COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF | SMCHD1, CAD, ESD | MEN1 3290/4885POLB 1349/4885KMT2A 872/4885 |
| US-20060111464-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | CAD, SMCHD1, SUPT16H | MEN1 3145/4885POLB 536/4885KMT2A 2006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.